Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZURE-LDL: AZD0780 in Patients With Elevated LDL-C and ASCVD
NCT07000123Phase 3Active, not recruiting
- Sponsor
- AstraZeneca
- Start
- May 2025
- Primary completion
- Jan 2027
- Modality
- Small Molecules
- Countries
- 22
01
Overview
A Phase 3 trial of laroprovstat in hypercholesterolemia, sponsored by AstraZeneca. Started May 2025; status: active, not recruiting.
02
Drugs
laroprovstat
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT07000123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07000123.